Jiangsu Hengrui Medicine Co., Ltd. (HKG:1276)

Jiangsu Hengrui Medicine Statistics

Total Valuation

HKG:1276 has a market cap or net worth of HKD 465.52 billion. The enterprise value is 421.98 billion.

Market Cap	465.52B
Enterprise Value	421.98B

Important Dates

The last earnings date was Monday, October 27, 2025.

Earnings Date	Oct 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	258.20M
Shares Outstanding	n/a
Shares Change (YoY)	+1.59%
Shares Change (QoQ)	+3.15%
Owned by Insiders (%)	0.12%
Owned by Institutions (%)	26.06%
Float	3.70B

Valuation Ratios

The trailing PE ratio is 57.04 and the forward PE ratio is 44.68.

PE Ratio	57.04
Forward PE	44.68
PS Ratio	13.75
PB Ratio	7.10
P/TBV Ratio	7.34
P/FCF Ratio	43.51
P/OCF Ratio	35.65
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 44.80, with an EV/FCF ratio of 39.44.

EV / Earnings	51.70
EV / Sales	12.47
EV / EBITDA	44.80
EV / EBIT	49.45
EV / FCF	39.44

Financial Position

The company has a current ratio of 6.55, with a Debt / Equity ratio of 0.00.

Current Ratio	6.55
Quick Ratio	5.95
Debt / Equity	0.00
Debt / EBITDA	0.01
Debt / FCF	0.01
Interest Coverage	535.24

Financial Efficiency

Return on equity (ROE) is 14.34% and return on invested capital (ROIC) is 9.34%.

Return on Equity (ROE)	14.34%
Return on Assets (ROA)	8.37%
Return on Invested Capital (ROIC)	9.34%
Return on Capital Employed (ROCE)	12.92%
Revenue Per Employee	1.67M
Profits Per Employee	403,300
Employee Count	20,238
Asset Turnover	0.53
Inventory Turnover	1.61

Taxes

In the past 12 months, HKG:1276 has paid 1.11 billion in taxes.

Income Tax	1.11B
Effective Tax Rate	11.94%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	82.65
200-Day Moving Average	n/a
Relative Strength Index (RSI)	40.09
Average Volume (20 Days)	3,613,276

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1276 had revenue of HKD 33.86 billion and earned 8.16 billion in profits. Earnings per share was 1.27.

Revenue	33.86B
Gross Profit	29.22B
Operating Income	8.54B
Pretax Income	9.28B
Net Income	8.16B
EBITDA	9.37B
EBIT	8.54B
Earnings Per Share (EPS)	1.27

Balance Sheet

The company has 44.24 billion in cash and 90.10 million in debt, giving a net cash position of 44.15 billion.

Cash & Cash Equivalents	44.24B
Total Debt	90.10M
Net Cash	44.15B
Net Cash Per Share	n/a
Equity (Book Value)	65.61B
Book Value Per Share	9.75
Working Capital	47.59B

Cash Flow

In the last 12 months, operating cash flow was 13.06 billion and capital expenditures -2.36 billion, giving a free cash flow of 10.70 billion.

Operating Cash Flow	13.06B
Capital Expenditures	-2.36B
Free Cash Flow	10.70B
FCF Per Share	n/a

Margins

Gross margin is 86.31%, with operating and profit margins of 25.22% and 24.10%.

Gross Margin	86.31%
Operating Margin	25.22%
Pretax Margin	27.42%
Profit Margin	24.10%
EBITDA Margin	27.66%
EBIT Margin	25.22%
FCF Margin	31.59%

Dividends & Yields

HKG:1276 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	17.06%
Buyback Yield	-1.59%
Shareholder Yield	-1.59%
Earnings Yield	1.75%
FCF Yield	2.30%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:1276 has an Altman Z-Score of 27.17 and a Piotroski F-Score of 5.

Altman Z-Score	27.17
Piotroski F-Score	5